This is consistent with previous observations that an approximately 50 % reduction of CCN2 expression by genetic deletion or siRNA was sufficient to significantly attenuate models of diabetic nephropathy and obstructive nephropathy (Yokoi et al. 2004; Guha et al. 2007; Nguyen et al. 2008). The gene discussed is CCN2; the disease is diabetic kidney disease.